Precigen, Inc. (PGEN): who owns it and who trades it
As of Nov 16, 2026, PGEN insiders reported 40 open-market sales worth $44.6M and 1 purchase worth $24.7K in the last 12 months, with 12% of the sale value made under pre-set 10b5-1 plans. The largest seller was Randal J Kirk (Director), with $35.8M. 6 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Precigen
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PGEN
211 funds and institutions reported PGEN shares worth $807M at the end of Q2 2026, about 40% of the company. The largest holder is Patient Capital Management, LLC with 5.3%.
Funds and institutions (13F) 40%Everyone else 60%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| Patient Capital Management, LLC | 19.04M | 5.34% | $109M | +7% |
| BlackRock, Inc. | 17.15M | 4.81% | $97.7M | +13% |
| State Street Corp | 12.00M | 3.37% | $68.4M | +10% |
| Diametric Capital, LP | 9.27M | 2.60% | $52.8M | +36% |
| Vanguard Capital Management LLC | 7.91M | 2.22% | $45.1M | +11% |
| Tang Capital Management LLC | 6.42M | 1.80% | $36.6M | No change |
| Boxer Capital Management, LLC | 5.15M | 1.44% | $29.4M | +47% |
| Geode Capital Management, LLC | 5.02M | 1.41% | $28.6M | +9% |
| Iridian Asset Management LLC | 4.03M | 1.13% | $23M | +12% |
| Occam Crest Management LP | 3.61M | 1.01% | $19.7M | -16% |
| Morgan Stanley | 3.47M | 0.97% | $19.8M | +44% |
| Goldman Sachs Group Inc | 3.41M | 0.96% | $19.4M | +2% |
| FMR LLC (Fidelity) | 2.57M | 0.72% | $14.7M | +29% |
| Vanguard Portfolio Management LLC | 2.21M | 0.62% | $12.6M | +4% |
| First Trust Advisors LP | 2.01M | 0.57% | $11.5M | – |
| Bank of America Corp | 1.85M | 0.52% | $10.5M | +26% |
| Arrowstreet Capital, Limited Partnership | 1.79M | 0.50% | $10.2M | +352% |
| Northern Trust Corp | 1.78M | 0.50% | $10.1M | +10% |
| Charles Schwab Investment Management Inc | 1.52M | 0.43% | $8.6M | +4% |
| Sixth Street Partners Management Company, L.P. | 1.52M | 0.43% | $8.6M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, PGEN insiders reported $24.7K of open-market purchases and $44.6M of sales. 12% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Jeffrey B Kindler | Director | Sale | 185,000 | $7.44 | $1.4M | Form 4 |
| Aug 25, 2026 | Rutul R Shah | Chief Operating Officer | Sale plan | 15,342 | $7.50 | $115K | Form 4 |
| Aug 25, 2026 | Phil Tennant | Chief Commercial Officer | Sale plan | 79,166 | $7.50 | $594K | Form 4 |
| Aug 21, 2026 | Nancy H Agee | Director | Purchase | 3,411 | $7.23 | $24.7K | Form 4 |
| Aug 21, 2026 | Rutul R Shah | Chief Operating Officer | Sale plan | 34,658 | $7.50 | $260K | Form 4 |
| Aug 6, 2026 | Rutul R Shah | Chief Operating Officer | Sale plan | 32,739 | $6.86 | $225K | Form 4 |
| Aug 3, 2026 | Rutul R Shah | Chief Operating Officer | Sale plan | 33,772 | $6.50 | $220K | Form 4 |
| Jul 31, 2026 | Harry Thomasian Jr. | CFO | Sale plan | 100,000 | $6.06 | $606K | Form 4 |
| Jul 1, 2026 | Harry Thomasian Jr. | CFO | Sale plan | 171,429 | $5.53 | $948K | Form 4 |
| Jun 29, 2026 | Harry Thomasian Jr. | CFO | Sale plan | 28,571 | $5.78 | $165K | Form 4 |
| Jun 29, 2026 | Rutul R Shah | Chief Operating Officer | Sale plan | 42,924 | $5.85 | $251K | Form 4 |
| Jun 29, 2026 | Helen Sabzevari | CEO | Sale plan | 346,836 | $5.89 | $2M | Form 4 |
| May 28, 2026 | Harry Thomasian Jr. | CFO | Sale | 41,884 | $4.36 | $183K | Form 4 |
| May 28, 2026 | Phil Tennant | Chief Commercial Officer | Sale | 30,272 | $4.36 | $132K | Form 4 |
| May 28, 2026 | Rutul R Shah | Chief Operating Officer | Sale | 42,703 | $4.36 | $186K | Form 4 |
| May 28, 2026 | Donald P. Lehr | Chief Legal Officer | Sale | 29,131 | $4.36 | $127K | Form 4 |
| May 28, 2026 | Helen Sabzevari | CEO | Sale | 119,250 | $4.36 | $520K | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 47,101 | $3.30 | $155K | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 168,794 | $3.30 | $557K | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 426,199 | $3.30 | $1.4M | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 50,797 | $3.30 | $168K | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 152,063 | $3.30 | $502K | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 370,847 | $3.30 | $1.2M | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 23,789 | $3.30 | $78.5K | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 2.33M | $3.30 | $7.7M | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 38,976 | $3.30 | $129K | Form 4 |
| Mar 30, 2026 | Randal J Kirk | Director | Sale | 1.11M | $3.30 | $3.7M | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 956,200 | $4.18 | $4M | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 9,931 | $4.18 | $41.5K | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 5,958 | $4.18 | $24.9K | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 11,917 | $4.18 | $49.8K | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 42,702 | $4.18 | $178K | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 159,321 | $4.18 | $666K | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 12,909 | $4.18 | $54K | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 38,729 | $4.18 | $162K | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 94,341 | $4.18 | $394K | Form 4 |
| Dec 22, 2025 | Randal J Kirk | Director | Sale | 555,119 | $4.18 | $2.3M | Form 4 |
| Dec 12, 2025 | Jeffrey B Kindler | Director | Sale | 235,467 | $3.63 | $855K | Form 4 |
| Nov 21, 2025 | Randal J Kirk | Director | Sale | 937,308 | $3.83 | $3.6M | Form 4 |
| Nov 20, 2025 | Randal J Kirk | Director | Sale | 942,832 | $4.08 | $3.8M | Form 4 |
| Nov 19, 2025 | Randal J Kirk | Director | Sale | 1.09M | $4.47 | $4.9M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Randal J Kirk | Director, 10% owner | – | $35.8M | Mar 30, 2026 |
| Helen Sabzevari | President and CEO | – | $2.6M | Jun 29, 2026 |
| Jeffrey B Kindler | Director | – | $2.2M | Aug 26, 2026 |
| Harry Thomasian Jr. | Chief Financial Officer | – | $1.9M | Jul 31, 2026 |
| Rutul R Shah | Chief Operating Officer | – | $1.3M | Aug 25, 2026 |
| Phil Tennant | Chief Commercial Officer | – | $726K | Aug 25, 2026 |
| Donald P. Lehr | Chief Legal Officer | – | $127K | May 28, 2026 |
| Nancy H Agee | Director | $24.7K | – | Aug 21, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PGEN short interest
High short interest. 12.5% of PGEN shares are sold short: about 1 share in 8. Over the last 12 reports the number of shares short went up 13%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 44.91M PGEN shares were sold short, 12.5% of the shares outstanding, down 3.2% from the report before. At the average daily volume of 5.25M shares, buying them all back would take about 8.6 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 44.91M | 12.53% | -3% | 5.25M | 8.6 |
| Oct 15, 2026 | 46.39M | 12.96% | -2% | 4.54M | 10.2 |
| Sep 30, 2026 | 47.55M | 13.28% | +12% | 6.44M | 7.4 |
| Sep 15, 2026 | 42.28M | 11.81% | +0% | 2.60M | 16.3 |
| Aug 31, 2026 | 42.18M | 11.78% | -0% | 5.33M | 7.9 |
| Aug 14, 2026 | 42.24M | 11.80% | +0% | 7.21M | 5.8 |
| Jul 31, 2026 | 42.04M | 11.74% | +2% | 3.78M | 11.1 |
| Jul 15, 2026 | 41.03M | 11.51% | -7% | 4.26M | 9.6 |
| Jun 30, 2026 | 44.22M | 12.40% | +2% | 5.81M | 7.6 |
| Jun 15, 2026 | 43.34M | 12.16% | +8% | 5.87M | 7.4 |
| May 29, 2026 | 40.25M | 11.29% | +1% | 4.21M | 9.6 |
| May 15, 2026 | 39.87M | 11.18% | +0% | 3.61M | 11.1 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Precigen company events
Precigen filed 5 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jun 24, 2026LeadershipAt the Annual Meeting of Stockholders of Precigen, Inc. held on June 18, 2026, the Company’s stockholders approved an amendment to the Precigen, Inc. 2023 Omnibus Incentive Plan, as amended, to increase the number of shares of common stock available for issuance thereunder by 7 million. Filing
- May 13, 2026ResultsReleased financial results. Filing
- Mar 25, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Precigen financials
Famous investors that hold PGEN
6 of the 50 well-known investors we track reported holding PGEN in their latest 13F filing. The largest position is Steve Cohen's, worth $16.3M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Steve Cohen · Point72 Asset Management | Q3 2026 | 1.90M | $16.3M | 0.0% | +50% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 1.55M | $13.3M | 0.0% | +89% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 639,500 | $5.5M | 0.0% | +6% |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 157,400 | $1.3M | 0.0% | New |
| Israel Englander · Millennium Management | Q3 2026 | 67,112 | $574K | 0.0% | -33% |
| Larry Robbins · Glenview Capital Management | Q3 2026 | 22,200 | $190K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Precigen, Inc. (PGEN) stock
Who owns the most PGEN stock?
The largest reported owner of Precigen, Inc. (PGEN) is Patient Capital Management, LLC, with 5.3% of the company. In total, 211 funds and institutions reported holding PGEN at the end of Q2 2026, together about 40% of the shares. See the largest owners.
Are PGEN insiders buying or selling?
In the last 12 months, PGEN insiders reported 1 open-market purchase worth $24.7K and 40 sales worth $44.6M. The latest trade was on Aug 26, 2026. See every trade.
What is the short interest in PGEN?
As of Oct 30, 2026, 44.91M PGEN shares were sold short, 12.5% of the shares outstanding, down 3.2% from the report before. At the average daily volume of 5.25M shares, buying them all back would take about 8.6 trading days (days to cover). See the history.
Which famous investors hold PGEN?
6 of the 50 well-known investors we track reported PGEN in their latest 13F filing, including Steve Cohen, Ken Griffin, Jim Simons. The largest position is worth $16.3M. See all holders.
Executive pay
Precigen's chief executive was paid a total of $5.4M for the year ended Dec 31, 2025, down 1% from $5.4M the year before. In the last 12 months, Precigen's executives and directors bought $24.7K of stock on the open market and sold $44.6M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.